Broach Lifecare Hospital Ltd vs Transgene Biotek Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Broach Lifecare Hospital Ltd is ₹ 12.7 as of 27 Oct 15:30 . The P/E Ratio of Broach Lifecare Hospital Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Broach Lifecare Hospital Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 34.7 crore on March 2021 to ₹ 25.38 crore on March 2025 . This represents a CAGR of -6.06% over 5 years The revenue of Broach Lifecare Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Transgene Biotek Ltd for the Jun '26 is ₹ 0.06 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the decline of -70% The ebitda of Broach Lifecare Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Transgene Biotek Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of -53.85% The net profit of Broach Lifecare Hospital Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Transgene Biotek Ltd changed from ₹ 0.2 crore to ₹ -0.39 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Broach Lifecare Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Broach Lifecare Hospital Ltd

Broach Lifecare Hospital Limited was incorporated as 'Broach Lifecare Hospital Private Limited' dated April 25, 2023, with the Registrar of Companies, Central Registration Centre.
Further, in accordance with the main objects, the Company acquired the sole proprietorship concerns of Dr. Jaykumar Narendra Vyas, the Promoter comprising of the Hospitals i.e.
Dr. Vyas's Heart Hospital and Dr. Vyas Hospital pursuant to a Business Transfer Agreement date July 17, 2023.
Thereafter, the Company was converted into a public limited Company and the name was changed to Broach Lifecare Hospital Limited' dated November 7, 2023 at ROC, Ahmedabad. The Company operates boutique Hospitals under the brand 'Maple Hospitals' and provides dedicated round-the-clock services to patients with heart ailments consisting of non-invasive cardiology services such as, 2D Echocardiography, Electrocardiography, Tread Mill Test, Holter monitoring, Ambulatory Blood Pressure Measurement, Stress test, Dobutamine Stress Echocardiography in June 2023, the Company ventured into interventional cardiac services such as, coronary angiography and stenting, percutaneous coronary intervention (PCI) and primary PCI for acute myocardial infarction as a division.

About Transgene Biotek Ltd

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India.
Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

FAQs for the comparison of Broach Lifecare Hospital Ltd and Transgene Biotek Ltd

Which company has a larger market capitalization, Broach Lifecare Hospital Ltd or Transgene Biotek Ltd?

Market cap of Broach Lifecare Hospital Ltd is 7 Cr while Market cap of Transgene Biotek Ltd is 17 Cr

What are the key factors driving the stock performance of Broach Lifecare Hospital Ltd and Transgene Biotek Ltd?

The stock performance of Broach Lifecare Hospital Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Broach Lifecare Hospital Ltd and Transgene Biotek Ltd?

As of October 31, 2026, the Broach Lifecare Hospital Ltd stock price is INR ₹12.7. On the other hand, Transgene Biotek Ltd stock price is INR ₹2.33.

How do dividend payouts of Broach Lifecare Hospital Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of Broach Lifecare Hospital Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.